Financial Reporting Standards (FRSs)

Interpretations of FRSs

Exposure Draft

Policy Statements and Speeches

Practice Directions

Singapore Government
ASC
 
 
  Home | About Us | Publication | Events | Useful Links
     
     
 

Accounting Standards

     
     
  News
     
     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Preface
Preface to Financial Reporting Standards
Framework
Framework for the Preparation and Presentation of Financial Statements
FRS 1
Presentation of Financial Statements
FRS 2
Inventories
FRS 7
Cash Flow Statements
FRS 8
Net Profit or Loss for the Period, Fundamental, Errors and Changed in Accounting Policies
FRS 10
Events after the Balance Sheet Date
FRS 11
Construction Contracts
FRS 12
Income Taxes
FRS 14
Segment Reporting
FRS 15
Information Reflecting the Effects of Changing Prices
FRS 16
Property, Plant and Equipment
FRS 17
Leases
FRS 18
Revenue
FRS 19
Employee Benefits
FRS 20
Accounting for Government Grants and Disclosure of Government Assistance
FRS 21
The Effects of Changes in Foreign Exchange Rates
FRS 22
Business Combinations
FRS 23
Borrowing Costs
FRS 24
Related Party Disclosures
FRS 25
Accounting for Investments
FRS 26
Accounting and Reporting by Retirement Benefit Plans
FRS 27
Consolidated Financial Statements and Accounting for Investments in Subsidiaries
FRS 28
Accounting for Investments in Associated
FRS 29
Financial Reporting in Hyperinflationary Economies
FRS 31
Financial Reporting of Interests in Joint Ventures
FRS 32
Financial Instruments: Disclosure and Presentation
FRS 33
Earnings Per Share
FRS 34
Interim Financial Reporting
FRS 35
Discontinuing Operations
FRS 36
Impairment of Assets
FRS 37
Provisions, Contingent Liabilities and Contingent Assets
FRS 38
Intangible Assets
FRS 39
Financial Instruments: Recognition and Measurement
FRS 41
Agriculture

FRS 101
First-time Adoption of Financial Reporting Standards

Implementation Guidance

   
 
Home > Accounting Standards > Interpretations of Financial Reporting Standards 2003 > INT FRS 28
 

Interpretation of Financial Reporting Standard


INT FRS 28

 

Business Combinations - "Date of Exchange" and Fair Value of Equity Instruments

 

Paragraph 11 of FRS 1, Presentation of Financial Statements, requires that financial statements should not be described as complying with Financial Reporting Standards unless they comply with all the requirements of each applicable Standard and each applicable Interpretation of the Financial Reporting Standard. INT FRSs are not intended to apply to immaterial items.

 

Reference: FRS 22, Business Combinations

 
ISSUE
 
 
  1. An enterprise may issue its own equity instruments as purchase consideration in a business combination accounted for as an acquisition under FRS 22. FRS 22.21 requires that an acquisition be accounted for at its cost, and that equity instruments issued by the acquirer be measured at their fair value at the date of exchange.

  2. If equity instruments issued as purchase consideration are quoted in a market and their market price at the date of exchange is not a reliable indicator of their fair value, FRS 22.24 indicates that price movements for a reasonable period before and after the announcement of the terms of the acquisition need to be considered.

  3. The issues are:
    1. what is the "date of exchange" when determining the fair value of equity instruments issued as purchase consideration in an acquisition;

    2. when is it appropriate to consider other evidence and valuation methods in addition to a published price at the date of exchange of a quoted equity instrument; and

    3. what information should be disclosed when a published price of a quoted equity instrument has not been used as the instruments' fair value, and what information should be disclosed when an equity instrument does not have a published price.

  4. FRS 22.65 requires the amount of an adjustment to the purchase consideration contingent on one or more future events to be included in the cost of an acquisition as at the date of acquisition if the adjustment is probable and the amount can be measured reliably. FRS 22.68 requires the cost of an acquisition to be adjusted when a contingency affecting the amount of the purchase consideration is resolved subsequent to the date of acquisition. Consequently, this Interpretation does not apply to equity instruments issued as adjustments to the purchase consideration contingent on one or more future events, unless the adjustments are probable and the amounts can be measured reliably as at the date of acquisition.
 
CONSENSUS

 

 
5.

When an acquisition is achieved in one exchange transaction (i.e., not in stages), the "date of exchange" is the date of acquisition; that is, the date when the acquirer obtains control over the net assets and operations of the acquiree. When an acquisition is achieved in stages (e.g., successive share purchases), the fair value of the equity instruments issued as purchase consideration at each stage should be determined at the date that each individual investment is recognised in the financial statements of the acquirer.

   
6. The published price at the date of exchange of a quoted equity instrument provides the best evidence of the instrument's fair value and should be used, except in rare circumstances. Other evidence and valuation methods should also be considered only in the rare circumstance when it can be demonstrated that the published price at that date is an unreliable indicator, and that the other evidence and valuation methods provide a more reliable measure of the equity instrument's fair value. The published price at the date of exchange is an unreliable indicator only when it has been affected by an undue price fluctuation or a narrowness of the market.
   
DISCLOSURE
   
7.

When a published price of an equity instrument issued as purchase consideration exists at the date of exchange, but has not been used as the instruments' fair value, an enterprise should disclose:

  1. that fact;

  2. the reasons why the published price is not the fair value of the equity instruments;

  3. the method and significant assumptions applied in determining the fair value; and

  4. the aggregate amount of the difference between the published price and the amount determined to be the fair value of the equity instruments.
   
8. When an equity instrument issued as purchase consideration does not have a published price at the date of exchange, an enterprise should disclose that fact and the method and significant assumptions applied in determining the fair value.
   
BASIS FOR CONCLUSIONS
 
9. As stated in FRS 22.22, when an acquisition is achieved in stages, the distinction between the date of acquisition and the date of the exchange transaction is important. When an acquisition is achieved in one exchange transaction there is no distinction between the date of exchange and the date of acquisition. Sub-paragraph 96(a) of the FRS Framework indicates that when assets are recorded at their historical cost, the assets are recorded at the fair value of the purchase consideration given to acquire them at the time of their acquisition. Therefore, when a business is acquired in one exchange transaction (i.e., not in stages), the fair value of the purchase consideration given is determined when control, as defined in FRS 22.8, of the net assets and operations of the acquiree is effectively transferred to the acquirer. When a business is acquired in stages (e.g., successive share purchases), the fair value of the purchase consideration given at each stage is determined when each individual investment is recognised in the financial statements of the acquirer.
   
10. FRS 22.24 indicates that marketable securities issued by the acquirer are measured at their fair value, which is their market price as at the date of the exchange transaction, provided that undue fluctuations or the narrowness of the market do not make the market price an unreliable indicator. Under FRS 39, an investment in an equity instrument is measured at its fair value, except in specified circumstances. Equity instruments have only one fair value in a market. FRS 39.99 indicates that the existence of published price quotations in an active market is normally the best evidence of fair value. Therefore, estimates of premiums for large, and discounts for small, blocks of equity instruments issued in comparison to that exchanged in observable transactions are not considered. When the published price of a quoted equity instrument on the date of an exchange is determined to be an unreliable indicator of its fair value, the information necessary to reliably estimate the effect of the undue fluctuation or market narrowness at that date is unlikely to be available due to the many factors that affect prices. Consequently, other evidence and valuation methods for determining fair value are considered only in the rare circumstance when it can be demonstrated that the published price is an unreliable indicator and that the other evidence and valuation methods provide a more reliable estimate of the equity instrument's fair value at the date of exchange.
   
Effective Date: INT FRS 28 comes into effect on 1st February 2003.
 
 
 
TOP
 

Last reviewed on 11 December 2007
This site is best viewed using IE 6.0 with 800 x 600 screen resolution

 
  Privacy Policy  |  Terms of Use